Joel B. Krier

5.3k total citations
25 papers, 761 citations indexed

About

Joel B. Krier is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Joel B. Krier has authored 25 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 8 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Joel B. Krier's work include Genomics and Rare Diseases (11 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Genomics and Diagnostics (6 papers). Joel B. Krier is often cited by papers focused on Genomics and Rare Diseases (11 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Genomics and Diagnostics (6 papers). Joel B. Krier collaborates with scholars based in United States, Australia and France. Joel B. Krier's co-authors include Robert C. Green, Heidi L. Rehm, Kurt D. Christensen, Calum A. MacRae, Amy L. McGuire, Jason L. Vassy, Michael F. Murray, Sarah S. Kalia, Isaac S. Kohane and Matthew S. Lebo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Internal Medicine.

In The Last Decade

Joel B. Krier

23 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel B. Krier United States 16 509 170 135 127 84 25 761
Sophia B. Hufnagel United States 6 805 1.6× 286 1.7× 207 1.5× 169 1.3× 142 1.7× 6 1.1k
Tanya N. Nelson Canada 21 450 0.9× 308 1.8× 72 0.5× 126 1.0× 276 3.3× 51 1.0k
Nathaly M. Sweeney United States 7 496 1.0× 211 1.2× 85 0.6× 61 0.5× 98 1.2× 11 679
Kalotina Machini United States 9 370 0.7× 109 0.6× 111 0.8× 68 0.5× 53 0.6× 15 518
Carrie L. Blout Zawatsky United States 12 300 0.6× 107 0.6× 58 0.4× 102 0.8× 76 0.9× 22 487
Laurel K. Willig United States 10 359 0.7× 162 1.0× 64 0.5× 43 0.3× 113 1.3× 14 538
Laura M. Amendola United States 21 989 1.9× 293 1.7× 287 2.1× 281 2.2× 184 2.2× 49 1.5k
Tatiana Tvrdik United States 11 224 0.4× 226 1.3× 129 1.0× 48 0.4× 60 0.7× 16 524
Anneliene Hechtelt Jonker France 13 256 0.5× 184 1.1× 41 0.3× 72 0.6× 45 0.5× 28 515
Marieke J.H. Baars Netherlands 16 394 0.8× 415 2.4× 33 0.2× 100 0.8× 79 0.9× 34 990

Countries citing papers authored by Joel B. Krier

Since Specialization
Citations

This map shows the geographic impact of Joel B. Krier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel B. Krier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel B. Krier more than expected).

Fields of papers citing papers by Joel B. Krier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel B. Krier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel B. Krier. The network helps show where Joel B. Krier may publish in the future.

Co-authorship network of co-authors of Joel B. Krier

This figure shows the co-authorship network connecting the top 25 collaborators of Joel B. Krier. A scholar is included among the top collaborators of Joel B. Krier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel B. Krier. Joel B. Krier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Novák, Péter, David M. Systrom, A. Veronica Witte, et al.. (2025). Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features. PubMed. 14. 100111–100111.
2.
Fieg, Elizabeth L., Natasha Y. Frank, Robert C. Green, et al.. (2024). Processes and outcomes from a clinical genetics e-consultation service managed by a primary care physician champion. SHILAP Revista de lepidopterología. 2. 101831–101831.
3.
Gammal, Roseann S., et al.. (2021). Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events. Drug Safety. 44(5). 601–607. 4 indexed citations
4.
Zawatsky, Carrie L. Blout, Nidhi Shah, Kalotina Machini, et al.. (2021). Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilization. The American Journal of Human Genetics. 108(12). 2224–2237. 32 indexed citations
5.
Stergachis, Andrew B., Joel B. Krier, Sai Merugumala, Gerard T. Berry, & Alexander Lin. (2021). Clinical utility of brain MRS imaging of patients with adult-onset non-cirrhotic hyperammonemia. Molecular Genetics and Metabolism Reports. 27. 100742–100742. 1 indexed citations
6.
Bendapudi, Pavan K., Onuralp Söylemez, Meaghan Colling, et al.. (2020). Rare Inherited Defects of the Complement System in Purpura Fulminans. Blood. 136(Supplement 1). 35–36. 2 indexed citations
7.
Stergachis, Andrew B., Kris M. Mogensen, Charbel C. Khoury, et al.. (2020). A retrospective study of adult patients with noncirrhotic hyperammonemia. Journal of Inherited Metabolic Disease. 43(6). 1165–1172. 12 indexed citations
8.
Morleo, Manuela, Vincenzo Nigro, Annalaura Torella, et al.. (2020). Identification of an Identical de Novo SCAMP5 Missense Variant in Four Unrelated Patients With Seizures and Severe Neurodevelopmental Delay. Frontiers in Pharmacology. 11. 599191–599191. 3 indexed citations
9.
Tóth-Petróczy, Ágnes, Nikkola Carmichael, Elicia Estrella, et al.. (2019). Homozygous TRPV4 mutation causes congenital distal spinal muscular atrophy and arthrogryposis. Neurology Genetics. 5(2). e312–e312. 16 indexed citations
10.
Li, George Z., Maria Clarissa Tio, Linda M. Pak, et al.. (2019). Noncirrhotic hyperammonemia after deceased donor kidney transplantation: A case report. American Journal of Transplantation. 19(11). 3197–3201. 10 indexed citations
11.
Murry, Jaclyn B., Kalotina Machini, Ozge Ceyhan‐Birsoy, et al.. (2018). Reconciling newborn screening and a novel splice variant in BTD associated with partial biotinidase deficiency: a BabySeq Project case report. Molecular Case Studies. 4(4). a002873–a002873. 4 indexed citations
12.
Holm, Ingrid A., Pankaj B. Agrawal, Ozge Ceyhan‐Birsoy, et al.. (2018). The BabySeq project: implementing genomic sequencing in newborns. BMC Pediatrics. 18(1). 225–225. 126 indexed citations
13.
Vassy, Jason L., Kurt D. Christensen, Carrie L. Blout Zawatsky, et al.. (2017). The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients. Annals of Internal Medicine. 167(3). 159–169. 110 indexed citations
14.
Lin, Angela E., Caroline Michot, Valérie Cormier‐Daire, et al.. (2016). Gain‐of‐function mutations in SMAD4 cause a distinctive repertoire of cardiovascular phenotypes in patients with Myhre syndrome. American Journal of Medical Genetics Part A. 170(10). 2617–2631. 45 indexed citations
15.
Krier, Joel B., Richard Barfield, Robert C. Green, & Peter Kraft. (2016). Reclassification of genetic-based risk predictions as GWAS data accumulate. Genome Medicine. 8(1). 20–20. 18 indexed citations
16.
Cipriano, Cara A., et al.. (2015). The Clinical Significance of Initial Pulmonary Micronodules in Young Sarcoma Patients. Journal of Pediatric Hematology/Oncology. 37(7). 548–553. 16 indexed citations
17.
Vassy, Jason L., Calum A. MacRae, Christine E. Seidman, et al.. (2015). A One-Page Summary Report of Genome Sequencing for the Healthy Adult. Public Health Genomics. 18(2). 123–129. 29 indexed citations
18.
Kong, Sek Won, In‐Hee Lee, Ignaty Leshchiner, et al.. (2014). Summarizing polygenic risks for complex diseases in a clinical whole-genome report. Genetics in Medicine. 17(7). 536–544. 30 indexed citations
19.
Vassy, Jason L., Denise Lautenbach, Heather M. McLaughlin, et al.. (2014). The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. Trials. 15(1). 85–85. 102 indexed citations
20.
Schnipper, Jeffrey L., Robert H. Ackerman, Joel B. Krier, & Melissa Honour. (2005). Diagnostic Yield and Utility of Neurovascular Ultrasonography in the Evaluation of Patients With Syncope. Mayo Clinic Proceedings. 80(4). 480–488. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sophia B. Hufnagel Breakdown of academic impact, for papers by Tanya N. Nelson Breakdown of academic impact, for papers by Nathaly M. Sweeney Breakdown of academic impact, for papers by Kalotina Machini Breakdown of academic impact, for papers by Carrie L. Blout Zawatsky Breakdown of academic impact, for papers by Laurel K. Willig Breakdown of academic impact, for papers by Laura M. Amendola Breakdown of academic impact, for papers by Tatiana Tvrdik Breakdown of academic impact, for papers by Anneliene Hechtelt Jonker Breakdown of academic impact, for papers by Marieke J.H. Baars
Rankless by CCL
2026